Browse Tenders
Showing 308,594 tenders
Spaceport Infrastructure Maintenance And Operations (Simo)
Daniel Hinsley
Spaceport Infrastructure Maintenance And Operations (Simo)<p><u>11/09/2026 - Update</u></p><p>The purpose of this notice is to provide Government responses to i...
Solicitation: W912Ch-26-B-0006 Nozzle, Fuel, Oil; Nsn: 4930-01-440-1085 - Amended
Robin Walker,Ciara Woodard-Brown
Solicitation: W912Ch-26-B-0006 Nozzle, Fuel, Oil; Nsn: 4930-01-440-1085 - Amended <p><strong>Please note new POC is Lyndsey Pena (lyndsey.m.pena.civ@army.mil)....
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient hydroxycarbamide (excl. Dafo. FTA), ATC L01XX05 f. d. Z. August 1st, 2026 - July 31st, 2028 (plus V. option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Referencing suppliers for fuel supply
PUBLIC TRANSPORT PURCHASING CENTER
<br/>The purpose of this Qualification System (SdQ) is to select one or more economic operators with a view to awarding specific contracts relating to the suppl...
Orders for vehicle insurance services through the CPO LT electronic catalog
PUBLIC INSTITUTION CPO LT
<br/>The validity period of the Dynamic Purchase System is extended<br/>
Open house drug discount agreements for the active ingredient desloratadine, ATC R06AX27
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Palonosetron (excl. Dafo. WKA), ATC A04AA05 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Open house drug discount agreements for the active ingredient hydrocortisone, ATC H02AB09
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...
Open house drug discount agreements for the active ingredient ustekinumab, ATC L04AC05
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Ofloxacin (excl. Dafo. KPG), ATC S01AE01 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient nifedipine, ATC C08CA05 for the period August 1st, 2026 - July 31st, 2028 (plus extension option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient granisetron (excl. Dafo. PFT), ATC A04AA02 f. d. Z. August 1, 2026 - July 31, 2028 (plus V. option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient varenicline, ATC N07BA03 for the period August 1st, 2026 - July 31st, 2028 (plus extension option 1x12 months)
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Open house drug discount agreements for the active ingredient alitretinoin, ATC D11AH04
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...
Open house drug discount agreements Ustekinumab, ATC L04AC05
AOK BAYERN - THE HEALTH INSURANCE COMPANY
<br/>It is not an open procedure, but rather a so-called open-house model! The form for the open process is only used because there is no form for the open-hous...
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient budesonide (FAM Kinpeygo and interchangeable medicines), ATC A07EA06 for the period August 1st, 2026 - July 31st, 2028
DAK HEALTH
<br/>§ 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be ...
Open house drug discount agreements for the active ingredient lisdexamfetamine, without hard capsules in a pack size of 30, ATC N06BA12
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...
GCS UniHA - Maintenance in Medical Imaging (MAINTIM 2020) SAD
GCS UNIHA
<br/>Maintenance in Medical Imaging (MAINTIM 2020) SAD<br/><br/>LOT-0001<br/>Cf. DCE<br/>
dynamic acquisition system relating to the purchase and leasing of vehicles
MINISTRY OF THE FRENCH COMMUNITY
<br/>dynamic acquisition system relating to the purchase and leasing of vehicles intended for the Administration and ministerial cabinets of the French Communit...
Open house drug discount agreements for the active ingredient naloxegol, ATC A06AH03
AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND
<br/>Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes vom 01.08.20...